S&P 500   3,846.83 (-0.16%)
DOW   31,086.12 (-0.29%)
QQQ   325.27 (-0.33%)
AAPL   138.06 (+0.87%)
MSFT   227.62 (+1.18%)
FB   276.11 (+1.19%)
GOOGL   1,899.25 (+0.80%)
AMZN   3,295.41 (-0.35%)
TSLA   835.77 (-1.09%)
NVDA   549.35 (-0.96%)
BABA   259.09 (-0.35%)
CGC   33.35 (-0.63%)
GE   11.09 (+0.18%)
MU   82.70 (-2.72%)
AMD   92.81 (+1.40%)
NIO   60.68 (+4.01%)
T   28.85 (+0.07%)
F   11.49 (-0.35%)
ACB   10.38 (-7.07%)
BA   205.03 (-1.15%)
DIS   173.37 (+1.22%)
NFLX   571.96 (-1.36%)
GILD   67.18 (+0.30%)
S&P 500   3,846.83 (-0.16%)
DOW   31,086.12 (-0.29%)
QQQ   325.27 (-0.33%)
AAPL   138.06 (+0.87%)
MSFT   227.62 (+1.18%)
FB   276.11 (+1.19%)
GOOGL   1,899.25 (+0.80%)
AMZN   3,295.41 (-0.35%)
TSLA   835.77 (-1.09%)
NVDA   549.35 (-0.96%)
BABA   259.09 (-0.35%)
CGC   33.35 (-0.63%)
GE   11.09 (+0.18%)
MU   82.70 (-2.72%)
AMD   92.81 (+1.40%)
NIO   60.68 (+4.01%)
T   28.85 (+0.07%)
F   11.49 (-0.35%)
ACB   10.38 (-7.07%)
BA   205.03 (-1.15%)
DIS   173.37 (+1.22%)
NFLX   571.96 (-1.36%)
GILD   67.18 (+0.30%)
S&P 500   3,846.83 (-0.16%)
DOW   31,086.12 (-0.29%)
QQQ   325.27 (-0.33%)
AAPL   138.06 (+0.87%)
MSFT   227.62 (+1.18%)
FB   276.11 (+1.19%)
GOOGL   1,899.25 (+0.80%)
AMZN   3,295.41 (-0.35%)
TSLA   835.77 (-1.09%)
NVDA   549.35 (-0.96%)
BABA   259.09 (-0.35%)
CGC   33.35 (-0.63%)
GE   11.09 (+0.18%)
MU   82.70 (-2.72%)
AMD   92.81 (+1.40%)
NIO   60.68 (+4.01%)
T   28.85 (+0.07%)
F   11.49 (-0.35%)
ACB   10.38 (-7.07%)
BA   205.03 (-1.15%)
DIS   173.37 (+1.22%)
NFLX   571.96 (-1.36%)
GILD   67.18 (+0.30%)
S&P 500   3,846.83 (-0.16%)
DOW   31,086.12 (-0.29%)
QQQ   325.27 (-0.33%)
AAPL   138.06 (+0.87%)
MSFT   227.62 (+1.18%)
FB   276.11 (+1.19%)
GOOGL   1,899.25 (+0.80%)
AMZN   3,295.41 (-0.35%)
TSLA   835.77 (-1.09%)
NVDA   549.35 (-0.96%)
BABA   259.09 (-0.35%)
CGC   33.35 (-0.63%)
GE   11.09 (+0.18%)
MU   82.70 (-2.72%)
AMD   92.81 (+1.40%)
NIO   60.68 (+4.01%)
T   28.85 (+0.07%)
F   11.49 (-0.35%)
ACB   10.38 (-7.07%)
BA   205.03 (-1.15%)
DIS   173.37 (+1.22%)
NFLX   571.96 (-1.36%)
GILD   67.18 (+0.30%)
Log in
NYSE:NTR

Nutrien Stock Forecast, Price & News

$53.17
-0.81 (-1.50 %)
(As of 01/22/2021 01:06 PM ET)
Add
Compare
Today's Range
$52.75
Now: $53.17
$53.57
50-Day Range
$46.51
MA: $49.87
$54.45
52-Week Range
$23.85
Now: $53.17
$55.12
Volume23,339 shs
Average Volume2.15 million shs
Market Capitalization$30.26 billion
P/E Ratio312.76
Dividend Yield3.37%
Beta0.9
Nutrien Ltd. provides crop inputs and services. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating approximately 2,000 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Nutrien logo

MarketRank

Overall MarketRank

1.71 out of 5 stars

Basic Materials Sector

80th out of 811 stocks

Agricultural Chemicals Industry

4th out of 20 stocks

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
CUSIPN/A
Phone306-933-8500
Employees22,300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20.02 billion
Cash Flow$5.35 per share
Book Value$39.92 per share

Profitability

Net Income$992 million

Miscellaneous

Market Cap$30.26 billion
Next Earnings Date2/17/2021 (Confirmed)
OptionableOptionable
$53.17
-0.81 (-1.50 %)
(As of 01/22/2021 01:06 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nutrien (NYSE:NTR) Frequently Asked Questions

How has Nutrien's stock been impacted by Coronavirus?

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NTR shares have increased by 67.0% and is now trading at $53.45.
View which stocks have been most impacted by COVID-19
.

Is Nutrien a buy right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 6 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Nutrien?

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Nutrien's CEO?

6,978 employees have rated Nutrien CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Nutrien's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Nutrien's next earnings date?

Nutrien is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Nutrien
.

How can I listen to Nutrien's earnings call?

Nutrien will be holding an earnings conference call on Wednesday, February 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) posted its quarterly earnings results on Monday, November, 2nd. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.07 by $0.16. The firm had revenue of $4.21 billion for the quarter, compared to analyst estimates of $3.83 billion. Nutrien had a return on equity of 4.19% and a net margin of 0.47%. The company's quarterly revenue was up .9% on a year-over-year basis. During the same period last year, the business posted $0.24 EPS.
View Nutrien's earnings history
.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien announced a quarterly dividend on Thursday, December 10th. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.346 per share on Thursday, January 14th. This represents a $1.38 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Nutrien's dividend history
.

Is Nutrien a good dividend stock?

Nutrien pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.37%. Nutrien does not yet have a strock track record of dividend growth. The dividend payout ratio of Nutrien is 82.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Nutrien will have a dividend payout ratio of 79.65% in the coming year. This indicates that Nutrien may not be able to sustain their current dividend.
View Nutrien's dividend history.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien issued an update on its FY 2020 After-Hours earnings guidance on Monday, November, 2nd. The company provided EPS guidance of 1.60-1.85 for the period.

What price target have analysts set for NTR?

19 brokerages have issued twelve-month price objectives for Nutrien's stock. Their forecasts range from $40.00 to $58.00. On average, they expect Nutrien's stock price to reach $49.00 in the next twelve months. This suggests that the stock has a possible downside of 8.3%.
View analysts' price targets for Nutrien
or view Wall Street analyst' top-rated stocks.

Are investors shorting Nutrien?

Nutrien saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 5,300,000 shares, a decline of 20.2% from the December 15th total of 6,640,000 shares. Based on an average daily volume of 1,380,000 shares, the short-interest ratio is currently 3.8 days. Currently, 0.9% of the company's shares are sold short.
View Nutrien's Short Interest
.

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are Nutrien's key executives?

Nutrien's management team includes the following people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 50, Pay $3.12M)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 56, Pay $1.7M)
  • Mr. Raef M. Sully, Exec. VP and CEO of Phosphate & Nitrogen (Age 53, Pay $1.06M)
  • Mr. Kenneth A. Seitz, Exec. VP & CEO of Potash (Age 51, Pay $2.5M)
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 50)
  • Mr. Michael R. Webb, Exec. VP and Chief HR & Admin. Officer
  • Mr. Richard Downey, VP of Investor & Corp. Relations
  • Ms. Noralee M. Bradley, Exec. VP & Chief Legal Officer
  • Mr. Kevin James Graham, Exec. VP & Pres of Sales (Age 42)

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Galibier Capital Management Ltd. (0.24%), Livingston Group Asset Management CO operating as Southport Capital Management (0.05%), Hexavest Inc. (0.04%), Signature Wealth Management Group (0.01%), Crossmark Global Holdings Inc. (0.01%) and Raymond James Trust N.A. (0.01%).

Which major investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Livingston Group Asset Management CO operating as Southport Capital Management, Addenda Capital Inc., DAVENPORT & Co LLC, Huntington National Bank, Investors Research Corp, Liberty One Investment Management LLC, and Cascade Investment Advisors Inc..

Which major investors are buying Nutrien stock?

NTR stock was bought by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Kestra Advisory Services LLC, Signature Wealth Management Group, Raymond James Trust N.A., Pacifica Partners Inc., Fruth Investment Management, and Crossmark Global Holdings Inc..

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $53.45.

How big of a company is Nutrien?

Nutrien has a market capitalization of $30.42 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

What is Nutrien's official website?

The official website for Nutrien is www.nutrien.com.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.